Bitco Pharmaceutical Private Limited

Bitco Pharmaceutical Private Limited - pharma in Delhi, India. Directors, charges & compliance details.
CIN U24230DL2022PTC393713 Incorporated 11 February 2022 ROC Delhi HQ Delhi, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2025
₹43.18 Lakh
▲ 78% YoY
Net profit · FY 2025
₹44,525
Net margin 1%
EBITDA · FY 2025
₹71,684
EBITDA margin 1.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Employees · EPFO
5
Provident fund records
Directors on board
4
As per MCA filings

About Bitco Pharmaceutical Private Limited

Data last updated:

Bitco Pharmaceutical Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 February 2022.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2022PTC393713.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Kumari Mukta Priyadarshni and Kusum.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit No F – 46 1st Floor Lsc Vardhman Central Mall Nehru Vihar Market, Delhi, India – 110054.

As per the financials filed for FY 2025, the company reported a revenue of ₹43.18 Lakh, a growth of 78% compared to the previous year. For the same year it recorded a net profit of ₹44,525 (net margin 1%) and EBITDA of ₹71,684 (EBITDA margin 1.7%).

The company has about 5 employees on its provident fund (EPFO) records.

Bitco Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-01-0027262).

Company Details of Bitco Pharmaceutical Private Limited
CIN U24230DL2022PTC393713
Registration Number 393713
Incorporation Date 11 February 2022
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-DL-01-0027262

Recognitions & Rankings of Bitco Pharmaceutical

MSME (Udyam registered) Ministry of MSME
Category
Micro (2022-23)
Udyam number
UDYAM-DL-01-0027262
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Unit No F – 46 1st Floor Lsc Vardhman Central Mall Nehru Vihar Market, Delhi, India – 110054
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Bitco Pharmaceutical Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Bitco Pharmaceutical Private Limited report

Financials, compliance, directors, charges, ownership and filings for Bitco Pharmaceutical Private Limited in one report.

Financials from FY 2022 Directors & ownership Charges & compliance

Business Activity of Bitco Pharmaceutical Private Limited

The main business activity of Bitco Pharmaceutical is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Bitco Pharmaceutical Private Limited FY 2025 filings available

Bitco Pharmaceutical Private Limited reported revenue of ₹43.18 Lakh (up 78% YoY) for FY 2025.

Revenue · FY 2025
₹43.18 Lakh ▲ 78%
Net profit · FY 2025
₹44,525 margin 1%
EBITDA · FY 2025
₹71,684 margin 1.7%

Compounded Annual Growth Rate (CAGR) of Bitco Pharmaceutical Private Limited

Revenue CAGR growth
1 year
▲ 78%
EBITDA CAGR growth
1 year
▲ 382%

Revenue rose 78% in the latest year. EBITDA rose 382% in the latest year. All are worked out from the filed statements.

Financial Statement Summary of Bitco Pharmaceutical Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations••••••••••••••••
Other Income••••••••••••••••
Total Revenue••••••••••••••••
Cost of Materials Consumed••••••••••••••••
Employee Benefit Expense••••••••••••••••
Finance Costs••••••••••••••••
Depreciation and Amortisation••••••••••••••••
Other Expenses••••••••••••••••
Total Expenses••••••••••••••••
EBITDA₹71,684••••••••••••
Profit Before Tax••••••••••••••••
Tax Expense••••••••••••••••
Net Profit (PAT)₹44,525••••••••••••
Balance Sheet
Share Capital••••••••••••••••
Reserves and Surplus••••••••••••••••
Net Worth (Total Equity)••••••••••••••••
Long-term Borrowings••••••••••••••••
Short-term Borrowings••••••••••••••••
Trade Payables••••••••••••••••
Total Liabilities••••••••••••••••
Fixed Assets••••••••••••••••
Investments••••••••••••••••
Inventories••••••••••••••••
Trade Receivables••••••••••••••••
Cash and Bank Balance••••••••••••••••
Total Assets••••••••••••••••

Financial Ratios of Bitco Pharmaceutical Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin1.7%••••••••••••
Net Profit Margin1%••••••••••••
Return on Equity (ROE)••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••
Return on Assets (ROA)••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••
Quick Ratio••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••
Interest Coverage Ratio••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••
Receivable Days••••••••••••••••
Payable Days••••••••••••••••
Inventory Days••••••••••••••••
Revenue Growth••••••••••••••••
Net Profit Growth••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Bitco Pharmaceutical are in the company report.

Premium access

Financial statements from FY 2022

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Bitco Pharmaceutical Private Limited

Bitco Pharmaceutical has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Kumari Mukta PriyadarshniDirector11 Feb 20224 Years 8 MonthsCurrent
KusumDirector11 Feb 20224 Years 8 MonthsCurrent
Rahul SharmaDirector22 Oct 20241 Years 11 MonthsCurrent
BabliDirector22 Oct 20241 Years 11 MonthsCurrent

Peer Comparison of Bitco Pharmaceutical Private Limited

Bitco Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Induct Pharmaceuticals Private Limited₹43.2 Lakh (FY 2025)••••••••-17.0%••••Surat, Gujarat, India
K. F. Plyarts Private Limited₹43.19 Lakh (FY 2022)••••••••-17.0%••••Kanpur, Uttar Pradesh, India
A.R. Remedies Private Limited₹43.19 Lakh (FY 2019)••••••••145.0%••••Lucknow, Uttar Pradesh, India
Vedik Alloys Private Limited₹43.19 Lakh (FY 2024)••••••••10.0%••••Thane, Maharashtra, India
Midastouch Dyes and Intermediaries Limited₹43.18 Lakh (FY 2025)••••••••7.0%••••Mumbai, Maharashtra, India
Bitco Pharmaceutical Private Limited this company₹43.18 Lakh (FY 2025)••••••••78.0%••••Delhi, India
RTN Pharma Private Limited₹43.18 Lakh (FY 2022)••••••••697.0%••••Hosur, Tamil Nadu, India
N2n Ingredients Private Limited₹43.17 Lakh (FY 2024)••••••••6.0%••••Tripunithura, Kerala, India
Vajire Ishwar Farmer Producer Company Limited₹43.16 Lakh (FY 2025)••••••••-10.0%••••Nanded, Maharashtra, India
Medicon Ophthalmics Private Limited₹43.15 Lakh (FY 2021)••••••••-36.0%••••New Delhi, Delhi, India
Fashpert Online Services Private Limited₹43.13 Lakh (FY 2024)••••••••15.0%••••Meerut, Uttar Pradesh, India

Peers are the five companies nearest above and the five nearest below Bitco Pharmaceutical by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Charges & Borrowings of Bitco Pharmaceutical Private Limited

Bitco Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Bitco Pharmaceutical Private Limited

Employment history and EPFO contributions of people linked to Bitco Pharmaceutical.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Bitco Pharmaceutical Private Limited

Bitco Pharmaceutical Private Limited has 5 board changes on record since 2022: 4 appointments and 1 cessation. The latest: Babli was appointed as Director on 22 Oct 2024.

AGM
Bitco Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Bitco Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Appointed
Babli was appointed as Director.
Appointed
Rahul Sharma was appointed as Director.
Ceased
Sonu Kumar ceased to be Director.
Appointed
Kumari Mukta Priyadarshni was appointed as Director.
Appointed
Kusum was appointed as Director.
Incorporation
11 Feb 2022
Bitco Pharmaceutical Private Limited was registered on 11 Feb 2022 with Roc Delhi Ii & aged 4 years 8 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Bitco Pharmaceutical Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Bitco Pharmaceutical Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Bitco Pharmaceutical Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Bitco Pharmaceutical Private Limited

Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Bitco Pharmaceutical Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bitco Pharmaceutical Private Limited

Bitco Pharmaceutical is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 February 2022 (4+ years old) and is registered under CIN U24230DL2022PTC393713.

Bitco Pharmaceutical reported revenue of ₹43.18 Lakh for FY 2025 (up 78% YoY).

Bitco Pharmaceutical has 4 current directors:

Bitco Pharmaceutical reported a net profit of ₹44,525 (net margin 1%) and EBITDA of ₹71,684 (EBITDA margin 1.7%) for FY 2025, as per its filed financial statements.

The CIN (Corporate Identification Number) of Bitco Pharmaceutical is U24230DL2022PTC393713. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Bitco Pharmaceutical was incorporated on 11 February 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Bitco Pharmaceutical by revenue are Induct Pharmaceuticals Private Limited, K. F. Plyarts Private Limited, A.R. Remedies Private Limited, Vedik Alloys Private Limited, Midastouch Dyes and Intermediaries Limited and 5 more, all in the same principal business activity (Wholesale Trading).

Babli was appointed as Director on 22 Oct 2024. Rahul Sharma was appointed as Director on 22 Oct 2024. Sonu Kumar ceased to be Director on 22 Oct 2024. Bitco Pharmaceutical has 5 board changes on record in total.

Yes, Bitco Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-01-0027262).

The registered office of Bitco Pharmaceutical is at Unit No F – 46 1st Floor Lsc Vardhman Central Mall Nehru Vihar Market, Delhi, India – 110054.

Bitco Pharmaceutical has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available